Eurofins Scientific Shares Slide Below €58, Down 15.5% Over Three Months
Eurofins Scientific shares fell by 2.85% to €57.34 in early afternoon trading, while the CAC 40 index declined by 0.76% during the session. The stock of the bioanalytical services specialist continues its downward trend following the end-of-April quarterly earnings release. Over three months, the decline has reached 15.53%.
Stock Falls Below Lower Bollinger Band
The price of Eurofins Scientific is now trading below the lower Bollinger band, set at €59.36. This configuration indicates potential overselling after a prolonged slide. The RSI at 39 remains below the 50 mark without reaching the low zone of 30. The stock is moving away from its 50-day (€64.87) and 200-day (€63.86) moving averages, which are now well above the current price. The next identified support level is at €60.76, already breached during the session.
Trajectory Hampered Since April Quarterly Report
The decline follows the publication of the first-quarter results on April 22, which led to a 10.78% drop in the stock on the same day. The company reported organic growth of 2.5%, hindered by adverse weather conditions in North America and the rationalization of unprofitable contracts. The company reaffirmed its organic growth targets for 2026 during this announcement. In mid-April, Eurofins also signed off on the sale of its MET Labs division to UL Solutions for €575 million, as part of a focus on life testing. The financial calendar points to the annual general meeting on May 27, followed by the half-year results on September 18.
